BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36744215)

  • 1. Inhibitory activity of
    Chattaraj B; Nandi A; Das A; Sharma A; Dey YN; Kumar D; R M
    Front Pharmacol; 2022; 13():982419. PubMed ID: 36744215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bioactive constituents from Enhydra fluctuans LOUR.
    Yadava RN; Singh SK
    Nat Prod Res; 2007 May; 21(6):481-6. PubMed ID: 17497419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytochemistry, Traditional Uses and Pharmacological Properties of Enhydra fluctuans Lour: a Comprehensive Review.
    Barua A; Alam MS; Junaid M; Akter Y; Afrose SS; Sharmin T; Akter R; Hosen SMZ
    Curr Pharm Biotechnol; 2021; 22(8):1061-1068. PubMed ID: 32962612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
    Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
    PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology and molecular modelling study of
    Chattaraj B; Khanal P; Nandi A; Das A; Sharma A; Mitra S; Dey YN
    J Biomol Struct Dyn; 2023; 41(24):15400-15410. PubMed ID: 36914227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial and cytotoxic activity of three bitter plants enhydra fluctuans, andrographis peniculata and clerodendrum viscosum.
    Amin MR; Mondol R; Habib MR; Hossain MT
    Adv Pharm Bull; 2012; 2(2):207-11. PubMed ID: 24312795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytochemical and in vitro biological investigations of methanolic extracts of Enhydra fluctuans Lour.
    Kuri S; Billah MM; Rana SM; Naim Z; Islam MM; Hasanuzzaman M; Ali MR; Banik R
    Asian Pac J Trop Biomed; 2014 Apr; 4(4):299-305. PubMed ID: 25182555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calcium oxalate crystallisation in vitro by an extract of Bergenia ciliata.
    Saha S; Verma RJ
    Arab J Urol; 2013 Jun; 11(2):187-92. PubMed ID: 26558080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
    De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
    PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.
    White DJ; Nancollas GH
    Calcif Tissue Int; 1987 Feb; 40(2):79-84. PubMed ID: 3105837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel inhibitor against human phosphoethanolamine cytidylyltransferase from phytochemicals of Citrus sinensis peel extract by in vitro and in silico approach.
    Victor PP; Narayanaswamy R; Kadry S; Gurunathan B
    Biotechnol Appl Biochem; 2023 Oct; 70(5):1565-1581. PubMed ID: 36824047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antilithiatic activity of the hydro-alcoholic extract of Cinnamomum zeylanicum Blume bark on calcium oxalate crystallization.
    Zaki S; Jahan N; Kalim M; Islam G
    J Integr Med; 2019 Jul; 17(4):273-281. PubMed ID: 30992200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiurolithiatic activity of Boldoa purpurascens aqueous extract: An in vitro and in vivo study.
    Mosquera DMG; Ortega YH; Quero PC; Martínez RS; Pieters L
    J Ethnopharmacol; 2020 May; 253():112691. PubMed ID: 32092500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.
    Webber D; Rodgers AL; Sturrock ED
    Urol Res; 2007 Dec; 35(6):277-85. PubMed ID: 17987287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant Potential of Crude Extract and Different Fractions of Enhydra fluctuans Lour.
    Sannigrahi S; Kanti Mazuder U; Kumar Pal D; Parida S; Jain S
    Iran J Pharm Res; 2010; 9(1):75-82. PubMed ID: 24363710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and lipid lowering effects of Enhydra fluctuans extract in cadmium treated normal and type-2 diabetic model rats.
    Hasan MN; Sabrin F; Rokeya B; Khan MSH; Ahmed MU; Matondo A; Billah MM; Akter S
    BMC Complement Altern Med; 2019 Oct; 19(1):278. PubMed ID: 31640743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.